MASTOCYTOSIS, SYSTEMIC

Clinical trials for MASTOCYTOSIS, SYSTEMIC explained in plain language.

Never miss a new study

Get alerted when new MASTOCYTOSIS, SYSTEMIC trials appear

Sign up with your email to follow new studies for MASTOCYTOSIS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Avapritinib rollover trial aims to confirm Long-Term safety for mastocytosis patients

Disease control Recruiting now

This study looks at the long-term safety of the drug avapritinib (AYVAKIT®) in people with systemic mastocytosis who have already been taking it and benefiting from it in a previous study. About 60 participants will continue receiving the drug and be monitored for serious side ef…

Matched conditions: MASTOCYTOSIS, SYSTEMIC

Phase: PHASE4 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

MASTOCYTOSIS, SYSTEMIC

Get alerted when new MASTOCYTOSIS, SYSTEMIC trials appear

Avapritinib rollover trial aims to confirm Long-Term safety for mastocytosis patients